Exogenous testosterone, whether prescribed as TRT or used at higher doses, suppresses the body’s own testosterone production. The suppression is not subtle: once you introduce testosterone from outside, your brain detects the elevated levels and dials down the hormonal signals that tell the testes to make their own. How deeply this shutdown runs, how it affects fertility, whether it reverses, and what you can do about it are all more nuanced than the simple yes-or-no framing suggests.
How the Shutdown Works
Your body regulates testosterone through a feedback loop involving the hypothalamus, the pituitary gland, and the testes. When testosterone levels are adequate, the hypothalamus reduces its release of the signaling hormone GnRH, which in turn reduces the pituitary’s output of two hormones called LH and FSH. LH is what tells the Leydig cells in the testes to produce testosterone, and FSH drives sperm production. When you add testosterone from an external source, your brain reads the elevated blood levels as a signal that the testes are producing plenty, and it cuts LH and FSH accordingly. The result is that testosterone production inside the testes drops steeply, and sperm production falls with it.1PubMed Central. Exogenous testosterone: a preventable cause of male infertility
The internal testosterone levels within the testes need to be far higher than what circulates in your blood for sperm production to work properly. TRT can suppress those internal levels so dramatically that sperm counts can fall to zero, a condition called azoospermia.1PubMed Central. Exogenous testosterone: a preventable cause of male infertility This happens regardless of the type of testosterone preparation used. Research measuring a proxy marker for intratesticular testosterone found a significant decrease across all formulations studied, including injections, gels, and pellets.2Fertility and Sterility. Differential impacts of short- versus long-acting testosterone therapy on intratesticular testosterone
The Delivery Method Changes How Deep the Suppression Goes
Not all TRT formulations suppress natural production to the same extent. The pattern is straightforward: preparations that maintain steadier, higher testosterone levels in the blood suppress LH and FSH more completely, while shorter-acting formulations with more variable levels produce less suppression. A systematic review found that long-acting injectables reduced FSH by about 86% and LH by roughly 72%, while daily gels and patches reduced FSH by about 60% and LH by around 59%. Short-acting intranasal testosterone gel produced the mildest suppression, dropping FSH by about 38% and LH by about 47%.3Sexual Medicine Reviews. The Effect of Longer-Acting vs Shorter-Acting Testosterone Therapy on Follicle Stimulating Hormone and Luteinizing Hormone
This gradient matters in practice. In a randomized trial comparing different testosterone delivery methods in men with low testosterone, subcutaneous pellet implants produced the most prolonged elevation in testosterone and the most sustained suppression of LH and FSH. Intramuscular injections caused more week-to-week fluctuation and less complete suppression. Oral testosterone undecanoate, which produced the most variable blood levels and kept testosterone within the normal range, did not significantly suppress LH and FSH at all.4PubMed. Randomized clinical trial of testosterone replacement therapy in hypogonadal men
The practical takeaway is that if minimizing the shutdown of your own production is a priority, shorter-acting formulations with more physiologic (less sustained) blood levels tend to be less suppressive. But even the mildest form still causes measurable decreases in signaling hormones. Suppression is a matter of degree, not an on-off switch.
Higher Doses Mean Deeper Suppression
Dose matters alongside delivery method. Classic research on healthy men given chronic testosterone at various doses showed a clear dose-dependent pattern: the higher the dose, the more complete the suppression of LH, FSH, and sperm production.5The Journal of Clinical Endocrinology & Metabolism. Effects of Chronic Testosterone Administration in Normal Men: Safety and Efficacy of High Dosage Testosterone and Parallel Dose-Dependent Suppression of Luteinizing Hormone, Follicle-Stimulating Hormone, and Sperm Production This distinction is relevant for the common question about whether “TRT doses” and “steroid cycle doses” produce the same kind of shutdown. Both suppress the axis, but supraphysiologic doses used in bodybuilding or anabolic steroid abuse create a more complete and potentially more prolonged suppression than standard replacement doses.6PubMed Central. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use
What This Means for Fertility
The fertility angle is the part that catches many men off guard. TRT is sometimes casually discussed as a performance or well-being enhancer, and men starting it in their 20s or 30s may not realize it can function almost like a male contraceptive. Sperm production depends on high testosterone levels inside the testes, and when external testosterone shuts down the signaling that drives local production, sperm counts plummet.7PubMed Central. Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic-androgenic steroids (AAS)
The irony is thick: testosterone is the male sex hormone, and supplementing it can make you infertile. A pooled analysis of 30 studies found that after men stopped testosterone therapy, about two-thirds regained a sperm density above 20 million per milliliter within six months, roughly 90% within 12 months, and essentially all by 24 months.8Fertility and Sterility. Medical therapies causing iatrogenic male infertility Those numbers sound reassuring, but waiting one to two years for your sperm count to recover is not a trivial ask if you and a partner are trying to conceive right now.
Some men never fully recover their baseline sperm counts spontaneously, though this appears to be a minority.6PubMed Central. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use The risk of prolonged or incomplete recovery is another reason clinicians increasingly emphasize fertility counseling before starting TRT, especially in younger men.
How Long Recovery Takes After Stopping
Beyond sperm counts, the recovery of the hormonal axis itself is slow. After men stopped two years of injectable testosterone undecanoate, their LH and FSH, which had been fully suppressed, recovered gradually over roughly 12 to 15 months.9European Journal of Endocrinology. Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections This is full hormonal recovery creeping back toward each man’s own pre-treatment baseline, not an overnight bounce-back.
Age is a factor. Older men are less likely to recover their testosterone production after a period of suppression, which makes sense given that testicular function naturally declines with age.10PubMed. Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study Duration and dose of prior use likely also play roles, though these are harder to pin down in controlled research because the populations who use high doses for years overlap heavily with anabolic steroid users, making clean data scarce.
A common concern is the “crash” that happens when a man stops TRT cold. During those weeks or months before the axis wakes up, testosterone levels can be quite low. Symptoms like fatigue, mood changes, low libido, and muscle loss during this window are what drive many men to restart therapy rather than wait out recovery. Some clinicians use a combination of hCG and other medications to bridge this gap and speed things along, though approaches vary widely and evidence for specific post-TRT recovery protocols is still relatively thin.8Fertility and Sterility. Medical therapies causing iatrogenic male infertility
Keeping Fertility Alive While on TRT
For men who need testosterone therapy but want to preserve their ability to have children, the most studied approach is adding hCG (human chorionic gonadotropin) alongside TRT. hCG mimics LH and directly stimulates the Leydig cells to keep producing testosterone internally, which helps maintain the intratesticular testosterone levels needed for sperm production. A study of men on TRT found that concurrent low-dose hCG injections preserved semen parameters, meaning sperm counts and quality stayed in a usable range.11PubMed. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy
Another option is selective estrogen receptor modulators, which work higher up in the chain by tricking the hypothalamus into thinking estrogen levels are lower than they are, prompting increased LH and FSH output. Prescribing these alongside TRT, or instead of TRT in milder cases, can support both testosterone levels and sperm production simultaneously.12PubMed Central. Systematic review of hormone replacement therapy in the infertile man The combination of TRT with hCG and sometimes additional agents has become increasingly common in clinical practice, though protocols are not standardized and tend to vary between practitioners.
Alternatives That Raise Testosterone Without Suppressing the Axis
If shutting down your own production is the part of TRT that worries you most, there are approaches that raise testosterone while working with the feedback loop rather than overriding it.
Enclomiphene citrate, a selective estrogen receptor modulator, stands out because it raises testosterone by stimulating the body’s own signaling chain. In a trial comparing enclomiphene to testosterone gel in obese men with low testosterone, both treatments raised total testosterone. But the enclomiphene group saw their LH and FSH increase, reflecting enhanced natural production, while the testosterone gel group saw those hormones fall, reflecting suppression. Crucially, enclomiphene maintained sperm counts in the normal range while the gel group experienced marked decreases in sperm production.13PubMed. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement A separate trial confirmed that enclomiphene increased both testosterone and sperm counts, with the LH and FSH changes consistent with normalization through the natural pathway rather than external override.14The Journal of Sexual Medicine. Oral Enclomiphene Citrate Stimulates the Endogenous Production of Testosterone and Sperm Counts in Men with Low Testosterone: Comparison with Testosterone Gel
A meta-analysis of randomized trials on clomiphene and enclomiphene found that these drugs raised total testosterone by an average of roughly 274 ng/dL compared to placebo and significantly increased both LH and FSH.15Archivos de EndocrinologÃa y Metabolismo. Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials The testosterone bump from enclomiphene tends to be more modest than what you get from injectable TRT, but for men whose levels are borderline low and who want to preserve fertility, that trade-off can be worthwhile. Enclomiphene is not currently FDA-approved as a standalone treatment for male hypogonadism in the United States, though it is used off-label and is available through some compounding pharmacies and men’s health clinics.
For men whose low testosterone is linked to excess body weight, weight loss itself can be a powerful intervention. Obesity-related low testosterone is considered a functional, reversible state rather than a permanent condition.16PubMed Central. Lowered testosterone in male obesity: mechanisms, morbidity and management A systematic review and meta-analysis found that both low-calorie diets and bariatric surgery significantly increased testosterone, with surgery producing a larger effect. The rise was directly proportional to the amount of weight lost and was accompanied by increases in the body’s own gonadotropin levels, meaning the hormonal axis was waking back up rather than being bypassed.17European Journal of Endocrinology. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis Resistance training and dietary changes can also help, particularly in men with obesity.18PubMed Central. Impact of Weight Loss on Testosterone Levels: A Review of BMI and Testosterone These strategies do not apply to men with primary testicular failure or organic causes of hypogonadism, but for the large number of men whose low testosterone is tied to metabolic health, they offer a path that preserves natural production entirely.
Measuring How Suppressed You Actually Are
Standard bloodwork on TRT typically includes total testosterone and sometimes LH and FSH. But those markers have limitations. Testosterone levels on TRT reflect the dose you are injecting, not what your testes are making. LH and FSH can tell you that signaling is suppressed, but they do not directly measure how well your Leydig cells (the testosterone-producing cells in the testes) are functioning underneath the suppression.
A newer marker called INSL3 (insulin-like factor 3) is attracting interest. INSL3 is a peptide made exclusively by mature Leydig cells, and unlike testosterone, its production is not acutely regulated by the feedback loop. Instead, it reflects the overall health and number of Leydig cells present.19Biology of Reproduction. INSL3 as a Biomarker of Leydig Cell Functionality Research has found that INSL3 is a sensitive marker of testicular suppression during testosterone exposure and could complement standard testosterone measurements for assessing Leydig cell function on and off TRT.20PubMed. Serum Insulin-like Factor 3, Testosterone, and LH in Experimental and Therapeutic Testicular Suppression INSL3 is not yet a routine clinical test, but it could eventually help clinicians and patients answer a question that current bloodwork handles poorly: how much testicular function is actually preserved under TRT?
Why Some Clinics Get This Wrong
A persistent misconception in some corners of men’s health marketing is that certain TRT protocols, particularly low-dose daily injections or microdosing, avoid shutting down natural production. The logic sounds plausible: smaller, more frequent doses create more stable blood levels, so maybe the brain does not “notice” and keeps signaling normally. The reality is more disappointing. While shorter-acting formulations do suppress LH and FSH less completely than long-acting ones, as covered earlier, all forms of exogenous testosterone cause measurable suppression. The degree varies, but zero suppression from any exogenous testosterone preparation has not been demonstrated in the published literature.
Another common misunderstanding is that hCG co-therapy “prevents” the shutdown. What hCG actually does is bypass the suppressed LH signal and directly stimulate the testes. The axis is still shut down at the brain level: LH and FSH are still suppressed. But the testes keep working because hCG is stepping in as a stand-in for LH.21PubMed Central. Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men This is a meaningful difference: hCG preserves testicular function and fertility during TRT, but it does not prevent the hypothalamic-pituitary suppression. If you stop both the TRT and the hCG, you still face a period of low hormone output while the brain restarts its signaling.
Testicular Volume and Physical Changes
Men on TRT commonly notice that their testicles get smaller over time. This is not psychological. When LH stimulation drops, the Leydig cells and Sertoli cells in the testes become less active, and the seminiferous tubules (where sperm are produced) shrink. The extent varies, but noticeable reduction in testicular volume is well-documented in men on long-term TRT.22PubMed Central. Clinician’s guide to the management of azoospermia induced by exogenous testosterone or anabolic-androgenic steroids hCG co-therapy can mitigate this by keeping the testes stimulated, which is one reason many men on TRT add it even if they are not currently trying to conceive.
The testicular atrophy associated with TRT is generally reversible once therapy is discontinued and the axis recovers, though the timeline for full volume recovery mirrors the slow hormonal recovery already described. For men on very long-term therapy, especially at high doses, there is some concern that prolonged inactivity of the Leydig cells could make recovery slower or less complete, though firm evidence on a point of no return is lacking.